Feiba-VH (Intravenous)
Generic name:anti-inhibitor coagulant complex (intravenous route) [ AN-tee-in-HIB-i-ter-co-AG-yoo-lant-kom-plex ]
Drug class:Miscellaneous coagulation modifiers
Medically reviewed by Drugs.com. Last updated on Apr 10, 2022.
Thromboembolic events have been reported during postmarketing surveillance following infusion of anti-inhibitor coagulant complex, particularly following the administration of high doses and/or in patients with thrombotic risk factors. Monitor patients receiving anti-inhibitor coagulant complex for signs and symptoms of thromboembolic events .
Commonly used brand name(s)
In the U.S.
- Autoplex T
- Feiba NF
- Feiba-VH
Available Dosage Forms:
- Powder for Solution
Therapeutic Class: Antihemophilic Agent
Uses for Feiba-VH
Anti-inhibitor coagulant complex injection is used to control bleeding episodes or bleeding during surgery in patients with hemophilia A and hemophilia B.
Anti-inhibitor coagulant complex contains substances called coagulation factors (e.g., non-activated Factors II, IX, and X, and activated Factor VII) that are normally produced in the body. These substances are used to stop bleeding of injuries for patients with hemophilia by helping the blood to clot.
This medicine is to be administered only by or under the supervision of your doctor.
Before using Feiba-VH
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Pediatric
No information is available on the relationship of age to the effects of anti-inhibitor coagulation complex injection in newborn babies. Safety and efficacy have not been established.
Geriatric
No information is available on the relationship of age to the effects of anti-inhibitor coagulation complex injection in geriatric patients. However, it should be used with caution in elderly patients.
Breastfeeding
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Interactions with medicines
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on t..
